Muscarinic acetylcholine receptor-mediated increase of angiotensin type 2 receptor mRNA in PC12 cells

NeuroReport

Volumn 9, Issue 17, 1998, Pages 3783-3789

  Shibata, Kazuhiko ^a   Ikuko, Makino ^a   Inoue, Kazuhide ^b   Katsuragi, Takeshi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Angiotensin type 2 receptor; Carbachol; Nitric oxide; PC12 cells; Protein kinase C

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ANGIOTENSIN 2 RECEPTOR; ATROPINE; CALPHOSTIN C; CARBACHOL; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; MESSENGER RNA; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

ANIMAL CELL; ARTICLE; CELL STRAIN; CONTROLLED STUDY; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR GENE; RECEPTOR UPREGULATION;

EID: 0032424242     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199812010-00004     Document Type: Article

References (23)

1. Peach MJ. Physiol Rev 57, 313-370 (1997).
2. Ganten D, Printz M, Phillips MI et al. The Renin-Angiotensin System in the Brain. Berlin: Springer, 1982.
3. Chiu AT, Herblin WF, McCall DF et al. Biochem Biophys Res Commun 165, 196-203 (1989).
4. Whitehead S, Mele M. Kamber B et al. Biochem Biophys Res Commun 163, 284-291 (1989).
5. Inagami T and Kitami Y. Hypertens Res 17, 87-97 (1994).
6. Grady EF, Sechi LA, Griffin CA at al. J Clin Invest 88, 921-933 (1991).
7. Kambayashi Y, Bardhan S, Takahashi K et al. J Biol Chem 268, 24543-24546 (1993).
8. Shibata K, Makino I, Shibagucht H et al. Biochem Biophys Res Commun 239, 633-637 (1997).
9. Kang J, Sumners C, Posner P et al. Am J Physiol 265, C607-C616 (1993).
10. Buisson B, Laflamme L, Bottari SP et al. J Biol Chem 270, 1670-1674 (1995).
11. Sumners C, Watkins LL and Raizada MK. J Neurochem 47, 1117-1126 (1986).
12. Felder CC. FASEB J 9, 619-625 (1995).
13. Wess J. Trends Pharmacol Sci 14, 308-313 (1993).
14. Inoue K and Kenimer JG. J Biol Chem 263, 8157-8161 (1988).
15. Shibata K, Komatsu, Misumi Y et al. Mol Brain Res 19, 115-120 (1993).
16. Balazs R, Jorgensen OS and Hack N. Neuroscience 27, 437-451 (1988).
17. Ashkenazi A, Peralta EG, Winslow JW et al. Cold Spring Harbor Symp Quant Biol 1, 263-272 (1988).
18. Pinkas-Kramarski R, Edelman R and Stein R. Neurosci Lett 108, 335-340 (1990).
19. Bauer MB, Murphy S and Gebhart GF. Neuroscience 82, 351-359 (1994).
20. Wang SZ, Lee SY, Zhu SZ et al. Pharmacology 55, 10-17 (1997).
21. Nakajima M, Horiuchi M, Morishita R et al. Hypertension 24, 378 (1994).
22. Makino I, Shibata K, Ohgami Y et al. Neuropeptides 30, 596-601 (1996).
23. Makino I, Shibata K, Shibaguchi H et al. Brain Res 804, 296-305 (1998).